Literature DB >> 11748656

Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C.

Ramazan Idilman1, Hülya Cetinkaya, Ismail Savaş, Nuray Aslan, Serpil Dizbay Sak, Mehmet Baştemir, Mustafa Sarioğlu, Irfan Soykan, Mithat Bozdayi, Alessandra Colantoni, Olcay Aydintuğ, Kadir Bahar, Ozden Uzunalimoğlu, David H Van Thiel, Numan Numanoğlu, Abdulkadir Dökmeci.   

Abstract

A number of disorders for which an association with hepatitis C virus infection exist. These disorders include essential mixed cryoglobulinemia, membranoproliferative glomerulonephritis, and idiopathic pulmonary fibrosis. This study was initiated to investigate the cellular content and lymphocyte subpopulations of bronchoalveolar lavage fluid obtained from individuals with chronic hepatitis C and to compare the results to those of controls. Eighteen patients with chronic hepatitis C (male/female, 6/12) and 14 healthy volunteers (male/female, 6/8), were studied. Bronchoalveolar lavage fluid was obtained from each; and the lymphocyte subtypes and the presence of HCV-RNA in the bronchoalveolar lavage fluid were determined. All anti-HCV positive subjects were HCV-RNA positive in serum. One (5.6%) had a HCV-RNA positive bronchoalveolar lavage. The total cell and neutrophil counts of the bronchoalveolar lavage fluid were significantly greater in patients with chronic hepatitis C as compared to controls (5,799.6 +/- 957.4 x 10(3)/ml vs. 1,835.7 +/- 447.8 x 10(3)/ml, P = 0.001; 1,175.8 +/- 634.7 x 10(3)/ml vs. 53.1 +/- 28.1 x 10(3)/ml, P = 0.029). In contrast, the lymphocyte, macrophage and eosinophil counts did not differ. No difference in the percentage, median or range of individual T cell subsets or B cell numbers in the bronchoalveolar lavage fluid existed between the groups. It is concluded that hepatitis C virus infection may be associated with an occult pulmonary inflammatory reaction manifested by an increased number of polymorphonuclear neutrophils in bronchoalveolar lavage fluid. This finding may contribute to the process that leads to idiopathic pulmonary fibrosis seen in a minority of cases of chronic hepatitis C. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748656

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 2.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

3.  Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.

Authors:  Siddharth A Mahure; Joseph A Bosco; James D Slover; Jonathan Vigdorchik; Richard Iorio; Ran Schwarzkopf
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

4.  Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis.

Authors:  Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Masahiro Kobayashi; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Miharu Hirakawa; Satoshi Saito; Kenji Ikeda; Hiromitsu Kumada
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

5.  Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.

Authors:  William A Fischer; Michael B Drummond; Christian A Merlo; David L Thomas; Robert Brown; Shruti H Mehta; Robert A Wise; Greg D Kirk
Journal:  COPD       Date:  2013-07-17       Impact factor: 2.409

6.  HIV infection is associated with diffusing capacity impairment in women.

Authors:  Meghan E Fitzpatrick; Matthew R Gingo; Cathy Kessinger; Lorrie Lucht; Eric Kleerup; Ruth M Greenblatt; David Claman; Claudia Ponath; Serena Fong; Laurence Huang; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

7.  Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.

Authors:  Rasoul Aliannejad; Mostafa Ghanei
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

8.  Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein.

Authors:  Jonathan P Moorman; S Matthew Fitzgerald; Deborah C Prayther; Steven A Lee; David S Chi; Guha Krishnaswamy
Journal:  Respir Res       Date:  2005-09-15

9.  Risk factors for interstitial lung disease: a 9-year Nationwide population-based study.

Authors:  Won-Il Choi; Sonila Dauti; Hyun Jung Kim; Sun Hyo Park; Jae Seok Park; Choong Won Lee
Journal:  BMC Pulm Med       Date:  2018-06-04       Impact factor: 3.317

10.  Coinfection with Hepatitis C and HIV Is a Risk Factor for Poor Outcomes After Total Knee Arthroplasty.

Authors:  Siddharth A Mahure; Joseph A Bosco; James D Slover; Jonathan M Vigdorchik; Richard Iorio; Ran Schwarzkopf
Journal:  JB JS Open Access       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.